Nebraska Cancer Specialist/Missouri Valley Cancer Consortium — Omaha, Nebraska

Nebraska Cancer Specialist/Missouri Valley Cancer Consortium is a clinical research site located in Omaha, Nebraska, United States 68106.

Crixeo Clinical Trials Trust Score: 6/100 (FAILING). This profile has not yet been claimed by the site owner.

Nebraska Cancer Specialist/Missouri Valley Cancer Consortium has participated in 2 clinical trials.

Therapeutic areas: Non-small Cell Lung Cancer (NSCLC), Acute Myeloid Leukemia (AML) With, FLT3 Mutation, Internal Tandem Duplication (ITD) or Tyrosine Kinase Domain (TKD).

Sponsors: Novartis Pharmaceuticals.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Omaha

Browse all research sites in Nebraska · View every site in Omaha

• Methodist Cancer Center at Methodist Hospital - Omaha
• Methodist Hospital Cancer Center at Nebraska Methodist Hospital - Omaha
• University of Nebraska Medical Center, College of Nursing
• Nebraska Medical Hospital
• University of Nebraska Medical Center, Lauritzen Outpatient Center
• Creighton University Psychiatry Research Center
• VA Medical Center, Omaha
• Marc Rendell, MD - Creighton University
• The Cardiac Center of Creighton University
• Methodist Hospital Cancer Center - Omaha
• University of Nebraska /ID# 203195
• Eppley Cancer Center, University of Nebraska Medical Center

Sponsor Feasibility Report

Trust Score: 6/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Nebraska Cancer Specialist/Missouri Valley Cancer Consortium?

Nebraska Cancer Specialist/Missouri Valley Cancer Consortium has a Crixeo Trust Score of 6/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Nebraska Cancer Specialist/Missouri Valley Cancer Consortium conducted?

Nebraska Cancer Specialist/Missouri Valley Cancer Consortium has 2 clinical trials on record. Their work covers Non-small Cell Lung Cancer (NSCLC), Acute Myeloid Leukemia (AML) With, FLT3 Mutation, Internal Tandem Duplication (ITD) or Tyrosine Kinase Domain (TKD).

Is Nebraska Cancer Specialist/Missouri Valley Cancer Consortium accredited by Crixeo Clinical Trials?

Nebraska Cancer Specialist/Missouri Valley Cancer Consortium has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Nebraska Cancer Specialist/Missouri Valley Cancer Consortium?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.